- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
Meningococcal vaccine refers to any of the vaccines used to prevent infection by Neisseria meningitides. The vaccines are between 85 and 100% effective for at least two years. They result in a decrease in meningitis and sepsis among populations where they are widely used. They are given either by injection into a muscle or just under the skin.
According to our latest study, the global Meningococcal Vaccine market size was valued at USD 269.6 million in 2022 and is forecast to a readjusted size of USD 359.8 million by 2029 with a CAGR of 4.2% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Meningococcal Vaccine key players include GSK, SANOFI PASTEUR S.A, Norvatis, Crucell, Medimmune, etc. Global top five players hold a share about 80%.
Europe is the largest market, with a share about 45%, followed by North America and China, having a total share about 40 percent.
In terms of product, Polysaccharide Meningtitis AC is the largest segment, with a share about 95%. And in terms of application, the largest application is 6 Months-15Year, followed by over 3 Year, over 2 Year, over 3 Months.
This report is a detailed and comprehensive analysis for global Meningococcal Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Meningococcal Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (10K Pcs), and average selling prices (USD/Pcs), 2018-2029
Global Meningococcal Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (10K Pcs), and average selling prices (USD/Pcs), 2018-2029
Global Meningococcal Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (10K Pcs), and average selling prices (USD/Pcs), 2018-2029
Global Meningococcal Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (10K Pcs), and ASP (USD/Pcs), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Meningococcal Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Meningococcal Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, GSK, Merck, CSL and Baxter, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Meningococcal Vaccine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Meningtits A
Polysaccharide Meningtitis AC
Meningitis ACYW
Market segment by Application
6 Months-15Year
over 3 Year
over 2 Year
over 3 Months
Major players covered
Novartis
GSK
Merck
CSL
Baxter
JN International Medical Corporation
Serum Institute of India
Bio-Med
China National Biotec Group
Hualan Bio
Walvax
Zhifei
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Meningococcal Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Meningococcal Vaccine, with price, sales, revenue and global market share of Meningococcal Vaccine from 2018 to 2023.
Chapter 3, the Meningococcal Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Meningococcal Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Meningococcal Vaccine market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Meningococcal Vaccine.
Chapter 14 and 15, to describe Meningococcal Vaccine sales channel, distributors, customers, research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Meningococcal Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Meningococcal Vaccine Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Meningtits A
1.3.3 Polysaccharide Meningtitis AC
1.3.4 Meningitis ACYW
1.4 Market Analysis by Application
1.4.1 Overview: Global Meningococcal Vaccine Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 6 Months-15Year
1.4.3 over 3 Year
1.4.4 over 2 Year
1.4.5 over 3 Months
1.5 Global Meningococcal Vaccine Market Size & Forecast
1.5.1 Global Meningococcal Vaccine Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Meningococcal Vaccine Sales Quantity (2018-2029)
1.5.3 Global Meningococcal Vaccine Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business
2.1.3 Novartis Meningococcal Vaccine Product and Services
2.1.4 Novartis Meningococcal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Novartis Recent Developments/Updates
2.2 GSK
2.2.1 GSK Details
2.2.2 GSK Major Business
2.2.3 GSK Meningococcal Vaccine Product and Services
2.2.4 GSK Meningococcal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 GSK Recent Developments/Updates
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business
2.3.3 Merck Meningococcal Vaccine Product and Services
2.3.4 Merck Meningococcal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Merck Recent Developments/Updates
2.4 CSL
2.4.1 CSL Details
2.4.2 CSL Major Business
2.4.3 CSL Meningococcal Vaccine Product and Services
2.4.4 CSL Meningococcal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 CSL Recent Developments/Updates
2.5 Baxter
2.5.1 Baxter Details
2.5.2 Baxter Major Business
2.5.3 Baxter Meningococcal Vaccine Product and Services
2.5.4 Baxter Meningococcal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Baxter Recent Developments/Updates
2.6 JN International Medical Corporation
2.6.1 JN International Medical Corporation Details
2.6.2 JN International Medical Corporation Major Business
2.6.3 JN International Medical Corporation Meningococcal Vaccine Product and Services
2.6.4 JN International Medical Corporation Meningococcal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 JN International Medical Corporation Recent Developments/Updates
2.7 Serum Institute of India
2.7.1 Serum Institute of India Details
2.7.2 Serum Institute of India Major Business
2.7.3 Serum Institute of India Meningococcal Vaccine Product and Services
2.7.4 Serum Institute of India Meningococcal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Serum Institute of India Recent Developments/Updates
2.8 Bio-Med
2.8.1 Bio-Med Details
2.8.2 Bio-Med Major Business
2.8.3 Bio-Med Meningococcal Vaccine Product and Services
2.8.4 Bio-Med Meningococcal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Bio-Med Recent Developments/Updates
2.9 China National Biotec Group
2.9.1 China National Biotec Group Details
2.9.2 China National Biotec Group Major Business
2.9.3 China National Biotec Group Meningococcal Vaccine Product and Services
2.9.4 China National Biotec Group Meningococcal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 China National Biotec Group Recent Developments/Updates
2.10 Hualan Bio
2.10.1 Hualan Bio Details
2.10.2 Hualan Bio Major Business
2.10.3 Hualan Bio Meningococcal Vaccine Product and Services
2.10.4 Hualan Bio Meningococcal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Hualan Bio Recent Developments/Updates
2.11 Walvax
2.11.1 Walvax Details
2.11.2 Walvax Major Business
2.11.3 Walvax Meningococcal Vaccine Product and Services
2.11.4 Walvax Meningococcal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Walvax Recent Developments/Updates
2.12 Zhifei
2.12.1 Zhifei Details
2.12.2 Zhifei Major Business
2.12.3 Zhifei Meningococcal Vaccine Product and Services
2.12.4 Zhifei Meningococcal Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Zhifei Recent Developments/Updates
3 Competitive Environment: Meningococcal Vaccine by Manufacturer
3.1 Global Meningococcal Vaccine Sales Quantity by Manufacturer (2018-2023)
3.2 Global Meningococcal Vaccine Revenue by Manufacturer (2018-2023)
3.3 Global Meningococcal Vaccine Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Meningococcal Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Meningococcal Vaccine Manufacturer Market Share in 2022
3.4.2 Top 6 Meningococcal Vaccine Manufacturer Market Share in 2022
3.5 Meningococcal Vaccine Market: Overall Company Footprint Analysis
3.5.1 Meningococcal Vaccine Market: Region Footprint
3.5.2 Meningococcal Vaccine Market: Company Product Type Footprint
3.5.3 Meningococcal Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Meningococcal Vaccine Market Size by Region
4.1.1 Global Meningococcal Vaccine Sales Quantity by Region (2018-2029)
4.1.2 Global Meningococcal Vaccine Consumption Value by Region (2018-2029)
4.1.3 Global Meningococcal Vaccine Average Price by Region (2018-2029)
4.2 North America Meningococcal Vaccine Consumption Value (2018-2029)
4.3 Europe Meningococcal Vaccine Consumption Value (2018-2029)
4.4 Asia-Pacific Meningococcal Vaccine Consumption Value (2018-2029)
4.5 South America Meningococcal Vaccine Consumption Value (2018-2029)
4.6 Middle East and Africa Meningococcal Vaccine Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Meningococcal Vaccine Sales Quantity by Type (2018-2029)
5.2 Global Meningococcal Vaccine Consumption Value by Type (2018-2029)
5.3 Global Meningococcal Vaccine Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Meningococcal Vaccine Sales Quantity by Application (2018-2029)
6.2 Global Meningococcal Vaccine Consumption Value by Application (2018-2029)
6.3 Global Meningococcal Vaccine Average Price by Application (2018-2029)
7 North America
7.1 North America Meningococcal Vaccine Sales Quantity by Type (2018-2029)
7.2 North America Meningococcal Vaccine Sales Quantity by Application (2018-2029)
7.3 North America Meningococcal Vaccine Market Size by Country
7.3.1 North America Meningococcal Vaccine Sales Quantity by Country (2018-2029)
7.3.2 North America Meningococcal Vaccine Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Meningococcal Vaccine Sales Quantity by Type (2018-2029)
8.2 Europe Meningococcal Vaccine Sales Quantity by Application (2018-2029)
8.3 Europe Meningococcal Vaccine Market Size by Country
8.3.1 Europe Meningococcal Vaccine Sales Quantity by Country (2018-2029)
8.3.2 Europe Meningococcal Vaccine Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Meningococcal Vaccine Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Meningococcal Vaccine Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Meningococcal Vaccine Market Size by Region
9.3.1 Asia-Pacific Meningococcal Vaccine Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Meningococcal Vaccine Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Meningococcal Vaccine Sales Quantity by Type (2018-2029)
10.2 South America Meningococcal Vaccine Sales Quantity by Application (2018-2029)
10.3 South America Meningococcal Vaccine Market Size by Country
10.3.1 South America Meningococcal Vaccine Sales Quantity by Country (2018-2029)
10.3.2 South America Meningococcal Vaccine Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Meningococcal Vaccine Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Meningococcal Vaccine Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Meningococcal Vaccine Market Size by Country
11.3.1 Middle East & Africa Meningococcal Vaccine Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Meningococcal Vaccine Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Meningococcal Vaccine Market Drivers
12.2 Meningococcal Vaccine Market Restraints
12.3 Meningococcal Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Meningococcal Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Meningococcal Vaccine
13.3 Meningococcal Vaccine Production Process
13.4 Meningococcal Vaccine Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Meningococcal Vaccine Typical Distributors
14.3 Meningococcal Vaccine Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Meningococcal Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Meningococcal Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Novartis Basic Information, Manufacturing Base and Competitors
Table 4. Novartis Major Business
Table 5. Novartis Meningococcal Vaccine Product and Services
Table 6. Novartis Meningococcal Vaccine Sales Quantity (10K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Novartis Recent Developments/Updates
Table 8. GSK Basic Information, Manufacturing Base and Competitors
Table 9. GSK Major Business
Table 10. GSK Meningococcal Vaccine Product and Services
Table 11. GSK Meningococcal Vaccine Sales Quantity (10K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. GSK Recent Developments/Updates
Table 13. Merck Basic Information, Manufacturing Base and Competitors
Table 14. Merck Major Business
Table 15. Merck Meningococcal Vaccine Product and Services
Table 16. Merck Meningococcal Vaccine Sales Quantity (10K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Merck Recent Developments/Updates
Table 18. CSL Basic Information, Manufacturing Base and Competitors
Table 19. CSL Major Business
Table 20. CSL Meningococcal Vaccine Product and Services
Table 21. CSL Meningococcal Vaccine Sales Quantity (10K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. CSL Recent Developments/Updates
Table 23. Baxter Basic Information, Manufacturing Base and Competitors
Table 24. Baxter Major Business
Table 25. Baxter Meningococcal Vaccine Product and Services
Table 26. Baxter Meningococcal Vaccine Sales Quantity (10K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Baxter Recent Developments/Updates
Table 28. JN International Medical Corporation Basic Information, Manufacturing Base and Competitors
Table 29. JN International Medical Corporation Major Business
Table 30. JN International Medical Corporation Meningococcal Vaccine Product and Services
Table 31. JN International Medical Corporation Meningococcal Vaccine Sales Quantity (10K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. JN International Medical Corporation Recent Developments/Updates
Table 33. Serum Institute of India Basic Information, Manufacturing Base and Competitors
Table 34. Serum Institute of India Major Business
Table 35. Serum Institute of India Meningococcal Vaccine Product and Services
Table 36. Serum Institute of India Meningococcal Vaccine Sales Quantity (10K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Serum Institute of India Recent Developments/Updates
Table 38. Bio-Med Basic Information, Manufacturing Base and Competitors
Table 39. Bio-Med Major Business
Table 40. Bio-Med Meningococcal Vaccine Product and Services
Table 41. Bio-Med Meningococcal Vaccine Sales Quantity (10K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Bio-Med Recent Developments/Updates
Table 43. China National Biotec Group Basic Information, Manufacturing Base and Competitors
Table 44. China National Biotec Group Major Business
Table 45. China National Biotec Group Meningococcal Vaccine Product and Services
Table 46. China National Biotec Group Meningococcal Vaccine Sales Quantity (10K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. China National Biotec Group Recent Developments/Updates
Table 48. Hualan Bio Basic Information, Manufacturing Base and Competitors
Table 49. Hualan Bio Major Business
Table 50. Hualan Bio Meningococcal Vaccine Product and Services
Table 51. Hualan Bio Meningococcal Vaccine Sales Quantity (10K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Hualan Bio Recent Developments/Updates
Table 53. Walvax Basic Information, Manufacturing Base and Competitors
Table 54. Walvax Major Business
Table 55. Walvax Meningococcal Vaccine Product and Services
Table 56. Walvax Meningococcal Vaccine Sales Quantity (10K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Walvax Recent Developments/Updates
Table 58. Zhifei Basic Information, Manufacturing Base and Competitors
Table 59. Zhifei Major Business
Table 60. Zhifei Meningococcal Vaccine Product and Services
Table 61. Zhifei Meningococcal Vaccine Sales Quantity (10K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Zhifei Recent Developments/Updates
Table 63. Global Meningococcal Vaccine Sales Quantity by Manufacturer (2018-2023) & (10K Pcs)
Table 64. Global Meningococcal Vaccine Revenue by Manufacturer (2018-2023) & (USD Million)
Table 65. Global Meningococcal Vaccine Average Price by Manufacturer (2018-2023) & (USD/Pcs)
Table 66. Market Position of Manufacturers in Meningococcal Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 67. Head Office and Meningococcal Vaccine Production Site of Key Manufacturer
Table 68. Meningococcal Vaccine Market: Company Product Type Footprint
Table 69. Meningococcal Vaccine Market: Company Product Application Footprint
Table 70. Meningococcal Vaccine New Market Entrants and Barriers to Market Entry
Table 71. Meningococcal Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 72. Global Meningococcal Vaccine Sales Quantity by Region (2018-2023) & (10K Pcs)
Table 73. Global Meningococcal Vaccine Sales Quantity by Region (2024-2029) & (10K Pcs)
Table 74. Global Meningococcal Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 75. Global Meningococcal Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 76. Global Meningococcal Vaccine Average Price by Region (2018-2023) & (USD/Pcs)
Table 77. Global Meningococcal Vaccine Average Price by Region (2024-2029) & (USD/Pcs)
Table 78. Global Meningococcal Vaccine Sales Quantity by Type (2018-2023) & (10K Pcs)
Table 79. Global Meningococcal Vaccine Sales Quantity by Type (2024-2029) & (10K Pcs)
Table 80. Global Meningococcal Vaccine Consumption Value by Type (2018-2023) & (USD Million)
Table 81. Global Meningococcal Vaccine Consumption Value by Type (2024-2029) & (USD Million)
Table 82. Global Meningococcal Vaccine Average Price by Type (2018-2023) & (USD/Pcs)
Table 83. Global Meningococcal Vaccine Average Price by Type (2024-2029) & (USD/Pcs)
Table 84. Global Meningococcal Vaccine Sales Quantity by Application (2018-2023) & (10K Pcs)
Table 85. Global Meningococcal Vaccine Sales Quantity by Application (2024-2029) & (10K Pcs)
Table 86. Global Meningococcal Vaccine Consumption Value by Application (2018-2023) & (USD Million)
Table 87. Global Meningococcal Vaccine Consumption Value by Application (2024-2029) & (USD Million)
Table 88. Global Meningococcal Vaccine Average Price by Application (2018-2023) & (USD/Pcs)
Table 89. Global Meningococcal Vaccine Average Price by Application (2024-2029) & (USD/Pcs)
Table 90. North America Meningococcal Vaccine Sales Quantity by Type (2018-2023) & (10K Pcs)
Table 91. North America Meningococcal Vaccine Sales Quantity by Type (2024-2029) & (10K Pcs)
Table 92. North America Meningococcal Vaccine Sales Quantity by Application (2018-2023) & (10K Pcs)
Table 93. North America Meningococcal Vaccine Sales Quantity by Application (2024-2029) & (10K Pcs)
Table 94. North America Meningococcal Vaccine Sales Quantity by Country (2018-2023) & (10K Pcs)
Table 95. North America Meningococcal Vaccine Sales Quantity by Country (2024-2029) & (10K Pcs)
Table 96. North America Meningococcal Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 97. North America Meningococcal Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 98. Europe Meningococcal Vaccine Sales Quantity by Type (2018-2023) & (10K Pcs)
Table 99. Europe Meningococcal Vaccine Sales Quantity by Type (2024-2029) & (10K Pcs)
Table 100. Europe Meningococcal Vaccine Sales Quantity by Application (2018-2023) & (10K Pcs)
Table 101. Europe Meningococcal Vaccine Sales Quantity by Application (2024-2029) & (10K Pcs)
Table 102. Europe Meningococcal Vaccine Sales Quantity by Country (2018-2023) & (10K Pcs)
Table 103. Europe Meningococcal Vaccine Sales Quantity by Country (2024-2029) & (10K Pcs)
Table 104. Europe Meningococcal Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 105. Europe Meningococcal Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 106. Asia-Pacific Meningococcal Vaccine Sales Quantity by Type (2018-2023) & (10K Pcs)
Table 107. Asia-Pacific Meningococcal Vaccine Sales Quantity by Type (2024-2029) & (10K Pcs)
Table 108. Asia-Pacific Meningococcal Vaccine Sales Quantity by Application (2018-2023) & (10K Pcs)
Table 109. Asia-Pacific Meningococcal Vaccine Sales Quantity by Application (2024-2029) & (10K Pcs)
Table 110. Asia-Pacific Meningococcal Vaccine Sales Quantity by Region (2018-2023) & (10K Pcs)
Table 111. Asia-Pacific Meningococcal Vaccine Sales Quantity by Region (2024-2029) & (10K Pcs)
Table 112. Asia-Pacific Meningococcal Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 113. Asia-Pacific Meningococcal Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 114. South America Meningococcal Vaccine Sales Quantity by Type (2018-2023) & (10K Pcs)
Table 115. South America Meningococcal Vaccine Sales Quantity by Type (2024-2029) & (10K Pcs)
Table 116. South America Meningococcal Vaccine Sales Quantity by Application (2018-2023) & (10K Pcs)
Table 117. South America Meningococcal Vaccine Sales Quantity by Application (2024-2029) & (10K Pcs)
Table 118. South America Meningococcal Vaccine Sales Quantity by Country (2018-2023) & (10K Pcs)
Table 119. South America Meningococcal Vaccine Sales Quantity by Country (2024-2029) & (10K Pcs)
Table 120. South America Meningococcal Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 121. South America Meningococcal Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 122. Middle East & Africa Meningococcal Vaccine Sales Quantity by Type (2018-2023) & (10K Pcs)
Table 123. Middle East & Africa Meningococcal Vaccine Sales Quantity by Type (2024-2029) & (10K Pcs)
Table 124. Middle East & Africa Meningococcal Vaccine Sales Quantity by Application (2018-2023) & (10K Pcs)
Table 125. Middle East & Africa Meningococcal Vaccine Sales Quantity by Application (2024-2029) & (10K Pcs)
Table 126. Middle East & Africa Meningococcal Vaccine Sales Quantity by Region (2018-2023) & (10K Pcs)
Table 127. Middle East & Africa Meningococcal Vaccine Sales Quantity by Region (2024-2029) & (10K Pcs)
Table 128. Middle East & Africa Meningococcal Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 129. Middle East & Africa Meningococcal Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 130. Meningococcal Vaccine Raw Material
Table 131. Key Manufacturers of Meningococcal Vaccine Raw Materials
Table 132. Meningococcal Vaccine Typical Distributors
Table 133. Meningococcal Vaccine Typical Customers
List of Figures
Figure 1. Meningococcal Vaccine Picture
Figure 2. Global Meningococcal Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Meningococcal Vaccine Consumption Value Market Share by Type in 2022
Figure 4. Meningtits A Examples
Figure 5. Polysaccharide Meningtitis AC Examples
Figure 6. Meningitis ACYW Examples
Figure 7. Global Meningococcal Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Meningococcal Vaccine Consumption Value Market Share by Application in 2022
Figure 9. 6 Months-15Year Examples
Figure 10. over 3 Year Examples
Figure 11. over 2 Year Examples
Figure 12. over 3 Months Examples
Figure 13. Global Meningococcal Vaccine Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global Meningococcal Vaccine Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Meningococcal Vaccine Sales Quantity (2018-2029) & (10K Pcs)
Figure 16. Global Meningococcal Vaccine Average Price (2018-2029) & (USD/Pcs)
Figure 17. Global Meningococcal Vaccine Sales Quantity Market Share by Manufacturer in 2022
Figure 18. Global Meningococcal Vaccine Consumption Value Market Share by Manufacturer in 2022
Figure 19. Producer Shipments of Meningococcal Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 20. Top 3 Meningococcal Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Top 6 Meningococcal Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Global Meningococcal Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 23. Global Meningococcal Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 24. North America Meningococcal Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 25. Europe Meningococcal Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 26. Asia-Pacific Meningococcal Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 27. South America Meningococcal Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 28. Middle East & Africa Meningococcal Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 29. Global Meningococcal Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 30. Global Meningococcal Vaccine Consumption Value Market Share by Type (2018-2029)
Figure 31. Global Meningococcal Vaccine Average Price by Type (2018-2029) & (USD/Pcs)
Figure 32. Global Meningococcal Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 33. Global Meningococcal Vaccine Consumption Value Market Share by Application (2018-2029)
Figure 34. Global Meningococcal Vaccine Average Price by Application (2018-2029) & (USD/Pcs)
Figure 35. North America Meningococcal Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 36. North America Meningococcal Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 37. North America Meningococcal Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 38. North America Meningococcal Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 39. United States Meningococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Canada Meningococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Mexico Meningococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Europe Meningococcal Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 43. Europe Meningococcal Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 44. Europe Meningococcal Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 45. Europe Meningococcal Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 46. Germany Meningococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. France Meningococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. United Kingdom Meningococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Russia Meningococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Italy Meningococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Asia-Pacific Meningococcal Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 52. Asia-Pacific Meningococcal Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 53. Asia-Pacific Meningococcal Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 54. Asia-Pacific Meningococcal Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 55. China Meningococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Japan Meningococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Korea Meningococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. India Meningococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Southeast Asia Meningococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Australia Meningococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. South America Meningococcal Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 62. South America Meningococcal Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 63. South America Meningococcal Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 64. South America Meningococcal Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 65. Brazil Meningococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Argentina Meningococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Middle East & Africa Meningococcal Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 68. Middle East & Africa Meningococcal Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 69. Middle East & Africa Meningococcal Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 70. Middle East & Africa Meningococcal Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 71. Turkey Meningococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Egypt Meningococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Saudi Arabia Meningococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. South Africa Meningococcal Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. Meningococcal Vaccine Market Drivers
Figure 76. Meningococcal Vaccine Market Restraints
Figure 77. Meningococcal Vaccine Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of Meningococcal Vaccine in 2022
Figure 80. Manufacturing Process Analysis of Meningococcal Vaccine
Figure 81. Meningococcal Vaccine Industrial Chain
Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
